SANDOZ A/S: Financial statements 2014
CVR: 27744532
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
SANDOZ A/S (CVR 27744532) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 1,188,656,586 and a net result of DKK 20,622,983 compared with DKK 25,209,040 the year before. That is an increase of 11.4% compared with the year before. The profit margin was 1.7%. Equity in the 2014 report amounted to DKK 473,754,989. The solvency ratio was 64.5%. The company had 72 employees in the financial year.
- Revenue
- DKK 1,188,656,586
- Gross Profit
- DKK 215,844,690
- Profit/Loss
- DKK 20,622,983
- Equity
- DKK 473,754,989
- Total Assets
- DKK 734,869,161
- Employees
- 72
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 1.2 mia. | 215.8 mio. | 20.6 mio. | 473.8 mio. | 72 |
| 2013 | 1.1 mia. | 202.4 mio. | 25.2 mio. | 453.1 mio. | 65 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
SANDOZ A/S has published its annual report for 2013. Revenue came to DKK 1,067,413,440, and the net result was DKK 25,209,040.
As of January 6, 2014, Rex Bernard Clements is registered as adm. dir. of SANDOZ A/S.
As of January 6, 2014, Paul Geymayer has stepped down as adm. dir. of SANDOZ A/S.
About SANDOZ A/S
SANDOZ A/S is a Danish company of the type Aktieselskab based in København S, founded in 2004. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named DURASCAN MEDICAL PRODUCTS A/S. The management consists of Lawrence Edward Mead. The board consists of Diane Marie DiGangi (chair), Lawrence Edward Mead and Nete Brændgaard. The company is owned by Sandoz AG. The company has 119 employees (2026). In 2025, the company reported revenue of DKK 2,515,342,000 and a net result of DKK 85,168,000 compared with DKK 48,047,000 the year before. Equity in the 2025 report amounted to DKK 662,792,000.